References
- Schnell T, Sontag S, Wanner J, et al. Endoscopic screening for Barrett's esophagus (BE), esophageal adenocarcinoma (AdCa) and other mucosal changes in ambulatory subjects with symptomatic gastroesophageal reflux (GER). (Abstract) Gastroenterology 1985;88(5 Pt 2):1576
- Sontag SJ, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990;99(3):613–20
- Heartburn across America: a Gallup Organization national survey. Princeton, NJ: Gallup Organization, 1988
- Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976;21(11):953–6
- Robinson MG, Decktor DL. Experience with omeprazole in erosive oesophagitis. Aliment Pharmacol Ther 1991;5(Suppl 1):69–77
- Washington N. Antacids and anti-reflux agents. Boca Raton, Fla: CRC Press, 1991:195–6
- Richter JE. A critical review of current medical therapy for gastroesophageal reflux disease. J Clin Gastroenterol 1986;8(Suppl 1):72–80
- Katz PO, Bishop SG, Lumpkin SM. Chronic dysphonia secondary to gastroesophageal reflux (GER): diagnosis with continuous simultaneous dual ambulatory pH monitoring (CDApHM). (Abstract) Gastroenterology 1988;94(May):A219
- Wiener GJ, Koufinan JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989:84(12): 1503–8
- Koelz HR. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs: an analysis of randomized clinical trials. Scand J Gastroenterol Suppl 1989;156:25–36
- Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992;326(12):786–92
- Brand DL, Eastwood IR, Manin D, et al. Esophageal symptoms, manometry, and histology before and after antireflux surgery: a long-term follow-up study. Gastroenterology 1979;76(6): 1393–401
- Negre JB, Markkula HT, Keyrilainen O, et al. Nissen fundoplication: results at 10 year follow-up. Am J Surg 1983;146(5):635–8
- Kitchin LI, Castell DO. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med 1991;151(3):448–54
- Johnson LF, DeMeester TR. Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal reflux. Dig Dis Sci 1981;26(8):673–80
- Eng J, Sabanathan S. Drug-induced esophagitis. Am J Gastroenterol 1991;86(9):1127–33
- Doman DB, Ginsberg AL. The hazard of drug-induced esophagitis. Hosp Pract (Off Ed) 1981;16(6):17–25
- Graham DY, Smith JL, Patterson DJ. Why do apparently healthy people use antacid tablets? Am J Gastroenterol 1983;78(5):257–60
- Grove O, Bekker C, Jeppe-Hansen MG, et al. Ranitidine and high-dose antacid in reflux oesophagitis: a randomized, placebo-controlled trial. Scand J Gastroenterol 1985;20(4):457–61
- Lanza FL, Smith V, Page-Castell JA, et al. Effectiveness of foaming antacid in relieving induced heartburn. South Med J 1986;79(3):327–30
- Weberg R, Berstad A. Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis. Scand J Gastroenterol 1989;24(4):401–6
- Decktor D, Maton P, Robinson M. Aluminum/magnesium hydroxide vs calcium carbonate: a comparison of the effects of Mylanta Double Strength and Turns E-X Tablets on intraesophageal and intragastric pH. (Abstract) Am J Gastroenterol 1992;87(9):1246
- Fraser AG, Prewett EJ, Hudson M, et al. The effect of ranitidine, Cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Ther 1991;5(3):263–72